600789 Shandong Lukang Pharmaceutical
- 8.08
- +0.29+3.72%
Shandong Lukang Pharmaceutical News
Announcement of Lukang Pharmaceutical on its holding subsidiary obtaining a notice of approval for a supplementary application for resorcinol injections and becoming a drug marketing license holder
Announcement of Lukang Pharmaceutical on obtaining a drug registration certificate for its holding subsidiary
Lukang Pharmaceutical\'s progress announcement on receiving compensation for land collection and storage in the Nanchang area
Announcement of Lukang Pharmaceutical on its holding subsidiary receiving approval notice for a supplementary application for dapoxetine hydrochloride tablets and becoming a drug marketing license holder
Announcement of Shandong Lukang Pharmaceutical's subsidiary obtaining pharmaceutical registration certificate.
Shandong Lukang Pharmaceutical's Announcement on obtaining the approval letter of active pharmaceutical ingredient market application for piperacillin.
Shandong Lukang Pharmaceutical's Announcement on the Completion of Land Transfer Procedures and Progress in the South Plant Area
Announcement from Shandong Lukang Pharmaceutical regarding the approval of the market application for non-budesonide active pharmaceutical ingredient.
Announcement of Lukang Pharmaceutical on obtaining a drug registration certificate for its holding subsidiary
Legal Opinion of Beijing Commerce Law Firm on the 2023 Annual General Meeting of Shareholders of Shandong Lukang Pharmaceutical Co., Ltd.
Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders of Lukang Pharmaceutical
Meeting materials for the 2023 Annual General Meeting of Shareholders of Lukang Pharmaceutical
Notice of Lukang Pharmaceutical on convening the 2023 Annual General Meeting of Shareholders
The use of non-operating capital of Lukang Pharmaceutical and other related financial transactions
Report of the Audit Committee of the Board of Directors of Lukang Pharmaceutical on the performance of supervisory duties by accounting firms in 2023
Special report of the board of directors of Lukang Pharmaceutical on the 2023 independent directors' independence self-inspection
2023 Internal Control Evaluation Report of Lukang Pharmaceutical
Lukang Pharmaceutical 2023 Board Audit Committee Performance Report
Announcement of Lukang Pharmaceutical on Acarbose obtaining a notice of approval for the marketing application of chemical raw materials
Announcement of Lukang Pharmaceutical on approval of levodopa\'s application for marketing of chemical raw materials
Analysis
Price Target
No Data
No Data